Day: September 3, 2022

Experts name 2 top ASX dividend shares to buy next week

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate

Are you looking for dividend shares to add to your income portfolio next week? If you are, then the two listed below could be top options.

Analysts have recently rated these dividend shares as buys. Here’s why they rate them highly:

GQG Partners Inc (ASX: GQG)

The first ASX dividend share that has been tipped as a buy is fund manager GQG.

The team at Goldman Sachs are positive on the company due to its strong investment performance, low fees, and attractive valuation. In respect to fees, Goldman highlights that GQG is in the lowest quartile among global peers. The broker also likes that GQG’s co-founders have the majority of their net wealth invested in the company and its investment strategies.

Another positive is the attractive yield on offer with its shares. Goldman is forecasting dividends per share of 8 cents in FY 2022 and 9 cents in FY 2023. Based on the current GQG share price of $1.56, this will mean yields of 5.1% and 5.8%, respectively.

The broker also sees decent upside for its shares with its buy rating and $1.92 price target.

Wesfarmers Ltd (ASX: WES)

Another ASX dividend share that has been tipped as a buy is Wesfarmers. It is the conglomerate behind a range of businesses such as Bunnings, Catch, Covalent Lithium, Kmart, Officeworks, and Priceline.

The team at Morgans remains very positive on the company. Particularly after Wesfarmers delivered a full year result that was “comfortably above expectations” last week.

Outside this, the broker likes the company due to its valuation. At 22x estimated FY 2023 earnings, the broker believes this is attractive for “a high-quality business with a diversified group of retail and industrial brands, solid balance sheet and strong leadership team.”

As for dividends, the broker is forecasting fully franked dividends per share $1.82 in FY 2022 and $1.89 in FY 2024. Based on the current Wesfarmers share price of $46.71, this will mean yields of 3.9% and 4%, respectively.

Morgans has an add rating and $55.60 price target on Wesfarmers’ shares.

The post Experts name 2 top ASX dividend shares to buy next week appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now

See The 5 Stocks
*Returns as of August 4 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/YAyaJkL

2 exciting ETFs named as buys by experts

A young woman sits with her hand to her chin staring off to the side thinking about her investments.

A young woman sits with her hand to her chin staring off to the side thinking about her investments.

If you’re wanting to buy some exchange traded funds (ETFs), then you certainly have a lot of options.

But which ones could be buys? Two that have been tipped as buys by analysts are listed below. Here’s what they are saying about them:

ETFS Battery Tech & Lithium ETF (ASX: ACDC)

If you’re wanting to get some exposure to the decarbonisation megatrend, then the ETFS Battery Tech & Lithium ETF could be one way to do it.

This popular ETF allows investors to buy a slice of companies involved in battery technology, electric vehicles, and lithium mining. This includes BYD, Mineral Resources Limited (ASX: MIN), Pilbara Minerals Ltd (ASX: PLS), Nissan, and Renault.

Jessica Amir from Saxo Markets is positive on the ETF. Especially for investors that aren’t keen on stock picking in the lithium sector. She commented:

If stock picking is not for you, and if you believe, like we do, that the electric vehicle industry and the critical minerals/ commodities will continue to see rising demand, and policy support, and also benefit from the world striving to be carbon neutral by 2050, then you could invest or trade in Global X Lithium & Battery Tech ETF (LIT) or ETFS Battery Tech & Lithium ETF (ACDC) that invests in about 30 of the biggest EV and battery technology companies in the world.

ETFS S&P Biotech ETF (ASX: CURE)

Another ETF that has been tipped as a buy is the ETFS S&P Biotech ETF. As its name implies, this ETF gives investors access to U.S. healthcare biotechnology companies.

The fund manager notes that these companies are engaged in the research, development and manufacturing of products based on genetic analysis and genetic engineering. This includes the development of immunotherapy treatments and vaccines to treat human diseases.

Among its largest holdings are ChemoCentryx, Global Blood Therapeutics, and Twist Bioscience.

Felicity Thomas from Shaw & Partners is a fan of the ETF. She recently told Livewire:

I like to buy ETFs for the long term. We have an ageing population, and what’s the most important thing in the world? Your health. Biotech, healthcare, and life sciences, that’s where you want to be invested over the next couple of decades.

The post 2 exciting ETFs named as buys by experts appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now

See The 5 Stocks
*Returns as of August 4 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/rZ1ufyO

2 small cap ASX shares that analysts rate as buys

Investing in the small side of the share market carries more risk than other areas.

But if your tolerance for risk allows for it, having a bit of exposure to this side of the market could be a boost for a balanced portfolio.

This is due to the potential returns on offer from promising small caps. If you can catch a small cap before it becomes a mid cap or even a large cap, the returns could be sensational.

With that in mind, here are two small cap ASX shares that analysts rate highly:

Airtasker Ltd (ASX: ART)

The first small cap ASX share that has been named as a buy is Airtasker.

It is growing online marketplace for local services with an estimated total addressable market of $600 billion across Australia, the UK, and the US.

Morgans is a big fan of the company. This is due to this significant market opportunity and its attractive business model. The broker also highlights that the company is operating in a market that is in the early stages of ecommerce adoption. It feels this puts Airtasker in a great position to benefit as the shift accelerates.

At the end of July, the broker retained its add rating with a trimmed price target of $1.25. This is more than double the current Airtasker share price.

PlaySide Studios Limited (ASX: PLY)

Another small cap ASX share that has been tipped as a buy is PlaySide Studios.

It is one of the largest video game developers in the ANZ region. Playside has developed a portfolio of games independently and in collaboration with studios such as Disney, Pixar, Warner Bros, and Nickelodeon.

In addition, over the last couple of years, the company has signed a number of work for hire deals with games publishing giants including 2K Games and Activision Blizzard. This could see the company work on some major titles for these gaming giants, which has the potential to give its reputation a huge boost and support further work for hire contract wins.

Last week, analysts at Ord Minnett retained their speculative buy rating and 85 cents price target. Based on the latest Playside share price of 67.5 cents, this implies potential upside of 26% for investors.

The post 2 small cap ASX shares that analysts rate as buys appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now

See The 5 Stocks
*Returns as of August 4 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Airtasker Limited. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/rOR6QuM

Why did the Dogecoin price tumble 12% in August?

A man wearing glasses and a purple vest holds his hand to his chin and wondersA man wearing glasses and a purple vest holds his hand to his chin and wonders

The Dogecoin (CRYPTO: DOGE) price is up 2.5% over the past 24 hours, currently trading for 6.25 US cents.

At that price, the crypto, which was created as a joke and features a Shiba Inu as its mascot, has a market cap of US$8.3 billion. This makes it the tenth biggest crypto in virtual circulation, according to CoinMarketCap. And that’s after falling 64% year to date.

There’s today’s price action for you.

Now, how did the Dogecoin price hold up in August, a month that saw the tech-heavy NASDAQ fall 4.6%?

Dogecoin price battered by rising interest rate outlook

Depending somewhat on your time zone, the Dogecoin price stood at 7.09 US cents as we ticked our calendars over to August.

By the time the clock struck midnight on 31 August, the dog-themed crypto was trading for 6.29 US cents, down 12.3% for the month. While nothing to cheer about, that performance did edge out the 14.8% losses posted by Bitcoin (CRYPTO: BTC) last month.

Investors holding the crypto throughout the month would have had to stomach plenty of volatility. Though that’s nothing new in the crypto sphere.

August saw the Dogecoin price trade as low as 6.02 US cents and as high as 8.86 US cents. A far cry from the all-time high of 73.76 US cents it hit on 8 May 2021.

As with Bitcoin and most other cryptos, the Dogecoin price struggled last month as investors were met with the reality that inflation across most of the globe isn’t likely to return to within central banks’ target ranges in quick order.

With the United States Federal Reserve and other central banks, including the Reserve Bank of Australia, flagging additional sizeable rate hikes in the months ahead to curb soaring prices, risk assets were broadly sold off across the board.

Dogecoin was no exception.

The post Why did the Dogecoin price tumble 12% in August? appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now

See The 5 Stocks
*Returns as of August 4 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Bitcoin. The Motley Fool Australia has positions in and has recommended Bitcoin. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://www.fool.com.au/2022/09/03/why-did-the-dogecoin-price-tumble-12-in-august/